2004 – “Off-label” prescribing becomes widespread

Announcement Date: January 1, 2004

“Off-label” prescribing of Risperdal becomes widespread. Unapproved uses include Alzheimer’s, autism spectrum disorders (ASDs) and attention-deficit/hyperactivity disorder (ADHD).